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ABSTRACT
Objectives. Our first objective was to
make an inventor' of available inStril-
ntents for the assessment of disabilities
in gait and related activities in patients
with rheumatic disorders. Our second
aim was to investigate which of these
instruments have acceptable method-
ological quality with regard to reliabil-
ity and validity Our third aim was to
investigate the assumption that the
evaluation of convergent construct
validity results in stronger correlations
when validated against a more similar
construct.
Materials. A computer-aided literature
search (1982-2001) of several databas-
es was performed to identify studies
focusing on the clinimetric properties
of instruments to assess impairments in
function in patients with rheumatic dis-
orders. Data on infra-rater reliability,
inter-rater reliability and convergent
construct validity were extracted in a
standardized manner and compared to
a priori defined criteria.
Results. in total 78 instruments were
eligible. Intra-observer reliability was
investigated for 28 instruments and
only 7 demonstrated good reliability as
well as good validity. Surprisingly, the
convergent construct validation against
a similar construct resulted often in low-
er correlations than validation against
ci less similar construct.
Conclusion. Based on the available
information, the Rheumatoid Arthritis
Quality of Life Scale and the Health
Assessment Questionnaire seem to be
the best instruments for assessing dis-
abilities in gait and related activities in
patients with theumatic disorders.
Introduction
In rehabilitation and allied health care
for patients with rheumatic disorders,
attention has shifted from disease sev-
erity to impairments, disabilities and
problems in participation (1). In partic-
ular, the development of the Interna-
tional Classification of Impairments,
Disabilities and Handicaps (ICIDH)
(2), after its revision renamed the Inter-
national Classification of Functioning,
Disabilities and Health Problems (ICF)
(3) has encouraged such a shift.
The main reason for this is that in rheu-
matology and allied health care, suit-
able treatment goals cannot be directly
derived from diseases, but should be
mainly based on the consequences of
diseases (4, 5). The ICF-classification
distinguishes the disease itself from
disease consequences and influencing
contextual factors (4). If the treatment
goals are expressed in terms of impair-
ment, disability or problems in partici-
pation (as in the ICF), these must be
demonstrated as reliable and valid (6,
7).
From this point of view it is essential to
choose adequate measurement instru-
ments, based on evidence of their
methodological quality (6, 8-13).
This article focuses on the clinimetric
properties of instruments to assess dis-
abilities in gait and related activities
(running, moving around on different
types of surfaces, climbing stairs and
handling special aids for transporta-
tion) in patients with rheumatic disor-
ders. The reason for focusing particu-
larly on disabilities in gait and related
activities is that this represents an es-
sential part of health-related quality of
life for these patients in the sense of
their being able to manage activities in-
dependently. Therefore, improvement
of the independence of the patient and
the quality of gait and related activities
is frequently included as a treatment
goal for patients with rheumatic disor-
ders.
The clinical variables that are exam-
ined need to be relevant for the treat-
ment goals and need to be coherent to
the prognosis of the disease (8-10, 14-
21). From this point of view it is essen-
tial to use the correct and most optimal
measurement instrument(s) for the
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Assessment of aspects of gait and relat-
ed activities. We recently demonstrated
that 3 7'4 of all 209 available instru-
ments to assess people with rheumatic
disorders focus on disabilities. partly
on disabilities in gait and related activi-
ties. A majority of 57% of all available
instruments to assess people with
rheumatic disorders focus on impair-
ments i4i.
In the ideal situation the choice for use
of a measurement instrument should be
based on the methodological quality of
the available instruments 16. 8-13).
However. an earlier study has demon-
strated a lack of information on the reli-
ability and y alidity of the instruments
in use for the assessment of muscu-
loskeletal disorders (11).
Reliabilit y is a basic characteristic of
an instrument that is required to be ade-
quate: if an instrument is not reliable it
yy ill not be useful. If the reliability is
sufficient, it is also relevant to assess
the alidity of the instrument. In the lit-
erature. several aspects of validity are
described. but because of the frequent
lack of a gold standard, the construct
validit y is the most commonly assessed
aspect, An instrument can be validated
by studying its correlation with a simi-
lar (optimally comparable) construct
for instance the same disability) or by
correlation with a less similar con-
struct, such as age, gender. etc. In 73%
of validity studies concerning construct
validity, the validity is based on its cor-
relation with constructs that measure a
totally different entity, and in I I% the
validity values are based on its correla-
tion with a similar construct (22).
In this study we distinguished various
levels of construct validity, because we
expected to find stronger correlations if
measurement instruments were validat-
ed against a similar construct than if
validated against a less similar con-
struct (12). If this were found to be so,
it could be relevant for the interpreta-
tion of validity studies.
The aim of this study was three-fold.
The first objective was to make an in-
ventory of available instruments for the
assessment of disabilities in gait and
related activities in patients with rheu-
matic disorders. Our second aim was to
investigate which of these instruments
have acceptable methodological quali-
ty with regard to reliability and validi-
ty. Our third aim was to investigate the
assumption that the evaluation of con-
vergent construct validity results in
stronger correlations when validated
against a similar construct.
Methods and materials
We performed a systematic review of
the literature on the clinimetric proper-
ties of measurement instruments for all
disabilities in gait and related activities
that are relevant in allied health care for
patients with rheumatic disorders.
Inclusion procedure
The following criteria were applied:
All studies had to focus on patients
suffering from rheumatoid arthritis,
seroncgative polyartlu• tis (including
psoriatic arthritis), osteoarthritis, an-
kylosing spondylitis, polymyositis or
fibrotnyalgia.
- The studies had to contain informa-
tion about the clinimetric properties
of instruments to assess disabilities
in gait and mobility.
- Different versions of an instrument
were considered as separate mea-
surement instruments.
- The questionnaire should contain at
least one question or a separate sub-
scale regarding gait or gait related
activities (running, moving around
on different types of surfaces, climb-
ing stairs and handling special aids
for transportation).
Only instruments for the measure-
ment of adult patients were included.
Literature search
First the Medline database was search-
ed for the period January 1982 — April
2001, using search terms for the rele-
vant rheumatic disorders and various
search terms for clinimetric properties
Infra-rater
reliability
(the detailed search strategy is avail-
able on request from the corresponding
author). The database of the Centre for
Documentation of the Dutch Institute
of Allied Health Care was also search-
ed for the period January 1988 — April
2001, using the same keywords. Fur-
thermore, the search in both databases
was repeated with the names of the
identified measurement instruments.
The English, French, German and
Dutch literature was included. The
search was subsequently augmented
with a manual search based on the ref-
erences of the relevant publications,
and therefore the search also yielded
also in some publications from before
1982.
Data extraction
All identified publications were assess-
ed independently on the basis of their
title and abstract by two reviewers (RS
and YK). In cases of disagreement
(3%) the article was also assessed by a
third reviewer. The assessment was
based on a standardized data collection
form (23) consisting of four sections:
general description (name, first author,
etc.), assessment domain (according to
the ICIDH-classification), method-
ological aspects (concerning reliability,
validity, responsiveness) and aspects of
feasibility. An explanation of all the ab-
breviations used in this article is given
in the Appendix.
Methodological criteria far
clinimetric properties
We investigated the following clinimet-
ric properties: intra-rater reliability,
construct validity and responsiveness.
To interpret the data on reliability and
validity we used criteria based on De
Jong et al. (24), Eliasziw et al. (25) and
Doeglas et al. (26) (Table I).
To investigate the influence of validat-
Table I. Cut-off points used for intro-rater reliability, inter-rater reliability and construct validity.
Validation against
	 Validation against
similar construct
	 dissimilar construct
Good x 2 0.85 x 2 0.65 x	 0.50
Moderate 0.65 < x < 0.85 0.50 < x < 0.65 0.40 < x < 0.50
Poor x < 0.65 x < 0.50 x < 0.40
x = Pearson's r, Spearman's rho or antra-Class Correlation Coefficient (ICC).
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Construct level
Construct I
ing against different constructs (vary-
ing from optimally comparable to dis-
similar) the construct validity was div-
ided into four clusters, in which the
constructs against which a measure-
ment instrument is validated are de-
fined according to their anticipated de-
gree of similarity to the instrument at
issue (Table II).
'Construct I' is the most convergent
construct, which means that the validi-
ty is measured against a variable which
is very similar to the variable to be val-
idated [for example: the HAQ-Mob
(variable mobility) that is validated
against the AIMS-Mob]. Validity is
defined as 'construct 2' if the instru-
ment is validated against instruments
that measure the same construct, as
well as other disabilities: for example,
if walking time is validated against an-
other instrument that measures disabili-
ties in walking, but also disabilities in
personal care. 'Construct 3' indicates
that the construct relates to other dis-
abilities than the disability to be vali-
dated: for example, if walking time is
validated against disabilities in inter-
personal relations. 'Construct 4' is the
least convergent validity, which means
that the construct that is used to vali-
date a variable relates to other domains
than the variable that is to be validated
[for example: a questionnaire for dis-
abilities in walking (variable mobility)
that is validated against an instrument
that is intended for the assessment of
muscle force].
We clustered 'construct 1' and 'con-
struct 2' as 'validation against a similar
construct' and 'construct 3', 'construct
4' as 'validation against a dissimilar
construct'. This distinction is also re-
flected in the criteria for validity in the
two last columns of Table I. The argu-
ment for this distinction is the fact that
'similar construct validity' comes clos-
est to the gold standard, and is there-
fore expected to result in stronger cor-
relations than the dissimilar construct
validity'(22).
Data analysis
The data were analysed in the Statisti-
cal Package for Social Sciences (SPSS)
8.0. A classification of instruments was
first made according to the type of dis-
abilities, based on the ICF-classifica-
tion (27).
The values of different studies of the
same instrument were pooled for each
clinimetric property that was assessed.
When the relevant information was
available, statistical pooling of the data
was performed if the measurement
instrument was validated against a sim-
ilar construct. The values were pooled
per construct. The pooled index is com-
posed of measurements, appropriately
weighted: E X = (n, x 1 ) / N, where X =
the pooled index, n, = the number of
persons included in the study, x, = the
value of methodological aspect (Pear-
son's r, Spearman's rho or intra-class
correlation coefficient (ICC)) in the
study, and N = the total number of per-
sons in all studies included in the pool-
ing. The pooled index was computed
for the Pearson's/Spearman's correla-
tion coefficients and the ICC values
separately. Values for the convergent
construct validity of multi-dimensional
instruments can be strongly influenced
by values of one or more sub-scales.
Therefore, whenever possible, the data
were also pooled for the separate sub-
scales.
Results
For the assessment of disabilities in
:Nit and related activities. 7S instru-
ments with a total of 36 subscales were
found. Two adapted versions of AIMS,
a multi-dimensional questionnaire.
were included in this analysis: AINIS1
and AINISS (for all abbreviations see
the Appendix ). Furthermore, beside the
HAQ also a muddied version of the
HAQ ( MHAQ) is included. AIMS:-
WaBe. AINIS2D-WaBe. FAS-Nlob,
HAQ-Walk. NIHAQ-Walk. SW and the
WT are intended onl n, for the assess-
ment of walking or related activities tin
this case climbing stairs): all other in-
struments or subscales are multi-di-
mensional and also measure other dis-
abilities and/or impairments. For 16 of
these 78 instruments there are no data
at all available regarding the method-
olo g ical quality of these instruments
(neither about reliability nor concern-
ing validity based on the described
constructs). The results of the remain-
ing 61 instruments are presented in
Table III.
Intra-observer reliability was investi-
gated for 28 instruments or subscales.
Sixteen out of these 28 met the criteri-
on of r/ICC  0.85, and 37 were found
to have good validity. For 32 instruments
and/or subscales construct validity was
investi gated in studies in which they
were validated a gainst the most similar
constructs (construct 1 or construct 2).
Seventeen out of these 32 met the crite-
rion of r/ICC ..0.65. For 35 instruments
and/or subscales construct validity was
investigated in studies in which they
were validated against a dissimilar con-
struct (construct 3 or construct 4).
If both reliability and validity are re-
quired to be 'good', 7 instruments meet
the criteria (shown in grey in Table HI).
In this study we did not report on the
responsiveness of the identified instru-
ments. So far, research into the respon-
siveness of measurement instruments is
hampered by the lack of consensus
regarding the preferred method. Of the
seven instruments that were found to
be valid and reliable in this study, two
(the DFI, and the RAQoL) are respon-
sive according to the conclusions of the
investigators (57, 87. 101). For HAQ,
SIP and WT there are conflicting re-
sults regarding responsiveness, while
the responsiveness of ASES-FSE and
Table II. Categorization of comparators utilized in assessing construct validity.
Definition
Validation against instruments that measure the same disability
Construct 2_ 	 Validation against instruments that measure the same disability us well as
other disabilities
Construct 3
	
Validation against instruments that measure other disabilities than the
instrument to be validated
Construct 4
	
Validation against generic instruments that measure disabilities as well as
impairments and participation problems
27
InstruniengfOrifiengining disability`in 'gait" R.A.11.M Swinkeis et al. 
dok ITI. 8eitzi^liw. .4rAi xalidity instmments for assessment of disabilities in cait or gait related activities in patients with rheumatic disorders.
Construct validit y if validated acainst instruments measuring
MS-6
Prl:,H*
kiAIS
IAISUr
A sn
'ail& IKE"
BM--
WTI"
FAS-
-Tr.in.,."
FKI"'"
HQ-Pti+
FS A I'
'
\RS--
0 ;RS- Apt.-
twelow###00
f
V.,) .
 I, ehli
11.
 \Q-tit iff+
ti.AQ-ODF "
tf	 trh4:'
if AQ-Walk''
Vf B- GloINFV4
I WEI, Mob"
KFrftr)
1.1.8P
MDR
MEW
fk()-'
NIFIAQ-0D1".
tit HAQ-OthAc'
si DAQ-Wal
PPIXY"
Mt
NE1P-PhysM'''"H'
OSR
talkOtt."
SF 16-Ph \ NA'
WWIN"t';g84to'
SIP-A14.•"
SRQ''
SW,*
womAc_Disab s,47 [1 lo4 14
wris-AiNfolase
to For
Inrra-rater
reliahiliyy
tl St-
The same
disability
The same
as well as other
disabilities
Other
disabilities
Impairments, disabilities
and participation problems
or general aspects
0.48*
0.88
0.79*
0.74 0.74*
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KFT have not been investigated up to
now.
Data on the validity of 49 instruments
and/or sub-scales are available. For 18
out of these 49 instruments, there are
data on the optimally comparable con-
struct validity as well as the imperfect
construct validity. In 7 of those 18 in-
struments the correlation for the similar
constructs proved to be stronger than
the values for validation against the
dissimilar constructs. For one instru-
ment the validity was the same for the
optimally comparable constructs as for
validation against the imperfect con-
structs. In 10 out of 18 instruments the
correlation values for the optimally
comparable constructs proved to be
lower than the values for validation
against the imperfect constructs.
Discussion
For the assessment of disabilities in
gait or gait related activities in patients
with rheumatic disorders, 78 instru-
ments have been identified. Sixteen out
of these 78 were found to have good re-
liability, and 37 were found to have
good validity. Only 7 out of the 78
measurement instruments had good
reliability as well as good validity.
The chosen methodological criteria in
this study were possibly too severe.
Though several authors in the literature
advocate a correlation of 0.4 for (con-
struct) validity as 'reasonably high'
(106-108) we only accepted a value of
0.50-0.65 as 'moderately strong' and a
value	 0.65 as 'strong' for construct
validity. The reason to deviate from the
level of 0.40 is the fact that it might
be expected that a more optimal com-
parable construct validity generates
higher values than validation against an
imperfect construct (22). However, our
study did not confirm this hypothesis.
This could possibly be explained by the
fact that the large majority of the
instruments for assessment of walking
and related activities are multi-dimen-
sional.
As demonstrated by Table III there are
several other instruments that could be
considered useful if the methodological
criteria were moderated slightly. How-
ever, the combination of acceptable re-
liability as well as validity is some-
times lacking. For example, in the liter-
ature it has been demonstrated that the
performance of the SF-36 in terms of
its psychometric and clinical validity,
may be affected by the clinical context
of the patient aroup in which it is
applied, and that satisfactory perfor-
mance cannot be guaranteed for all the
groups of conditions. The same point is
made for the E-QoL, which has been
validated in population surveys and
appears to perform well there: howev-
er, its value in rheumatic disease popu-
lations remains uncertain (Table III).
The problems of this scale (distribution
of scores, disconcordance with VAS at
lower levels of the E-QoL, and com-
pression of item range) suggest a limit-
ed role for this instrument in rheumato-
logic conditions at this time.
In this study, several levels of construct
validity were distinguished, based on
the hypothesis that validation against
an optimally comparable construct
should result in stronger correlations
than validation against a dissimilar
construct, However, the result of this
study do not confirm this hypothesis:
for the validity of 10 out of 18 instru-
ments, the values for validation against
an optimally comparable construct
proved to be lower than in case of vali-
dation against an imperfect construct.
This is opposite to the results of a com-
parable study on the validity of mea-
surement instruments for the assess-
ment of impairments in patients with
rheumatic disorders (109). The reason
for this discrepancy is unclear. A possi-
ble explanation could be the fact that
the large majority of instruments for
the assessment of walking and related
activities are multi-dimensional and for
the most part focus on disabilities other
than walking, whereas on the other
hand instruments for the assessment of
impairment more frequently only focus
on the impairment to be measured, and
not on other domains.
The group of what is defined as 'rheu-
matic disorders' (see criteria in inclu-
sion procedure) includes a variety of
diseases. We also focused on differ-
ences for subgroups in the rheumatic
disorders, because some measurement
instruments focus in particular on spe-
cific characteristics of those patient
populations and are developed just for
only those patients. For example, there
have been several instruments devel-
oped for ankylosing spondylitis that are
not relevant for patients with rheuma-
toid arthritis. The majority of the men-
tioned instruments are multi-dimen-
sional. At this time, for the assessment
of intervention in osteoarthritis of the
lower extremities, the WOMAC is gen-
erally recommended as the most sensi-
tive condition-specific instrument.
However, the responsiveness varies by
both subscale and intervention. Gener-
ally, the physical function subscale has
large effect sizes, particularly in hip
and knee arthroplasty patients.
Of the great number of available instru-
ments for the assessment of walking
and related activities, 'WT' and 'ST'
are the only instruments that measure
only walking or stair walking respec-
tively. In all other cases it concerns a
subscale of a more extensive and most-
ly multi-dimensional instrument that
measures various disabilities, not only
walking. Even in case of WT there are
different interpretations for patients
with rheumatoid arthritis than for
patients with osteoarthritis, total hip
replacement etc.
The fact that the majority of the instru-
ments are questionnaires in which
walking and related activities are only a
small part is the consequence of our
inclusion procedure. In other parts of
the study we only included: 1) instru-
ments which focus mainly (50% or
more of the items) on the impairment to
be measured; and 2) questionnaires
with a sub-scale for the impairment in
question that can be interpreted sepa-
rately as a single entity. This require-
ment was not possible here, because
applying this rule should result in only
two instruments (WT and SW). In fact
both instruments have moderate or
good reliability, but there is lack of in-
formation concerning their validity.
Combining reliability with validity
leaves 7 instruments that meet the crite-
ria. However, this does not mean that
all the others are neither reliable nor
valid, because reliability was calculat-
ed only for 28 instruments. In other
words, for 64% of the available instru-
ments the reliability is unknown. Ano-
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ther restriction concerning the low
number of data relating to reliability is
the fact that this review was restricted
to studies focusing on populations with
rheumatic disorders. The reliability and
validity of the instruments might just as
well have been investiaated in other
patient populations.
Based on the available information the
RAQoL and HAQ seem to be the best
available instruments: however, both
are multi-dimensional and the influ-
ence of certain subscales is not clear.
For example, it is worth noting that the
subscale HAQ-Walk has a very low
validity score (r = 0.23, construct I).
Both instruments could possibly result
in a lot of unnecessary data for clinical
use if the user is only interested in
walking and related activities. For that
reason the usefulness of RAQoL and
HAQ is under discussion if the inten-
tion is to measure only gait and related
activities. More attractive for clinical
use could be the WT and the SW: how-
ever, there is a lack of data concerning
the validity of those two.
In conclusion, for clinical applications
the user needs to balance the impor-
tance of the available reliability, validi-
ty and amount of ballast of some instru-
ments. Table III is intended as a guide
in this process of balancing.
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Appendix. List of abbreviations of measurement instruments and sub-scales.
Abbreviation Name of Measurement Instrument Abbreviations of Sub-Scales
AIMS Arthritis Impact Measurement Scale Disab Disabilities
GlobH Global Health
Mob Mobility
PhysA Physical Activities
PhysH Physical Health
PhysM Physical Mobility
AIMSD Arthritis Impact Measurement Scale — Dutch PhysA Physical Activities
AIMS2 Arthritis Impact Measurement Scale 2 WaBe Walking and Bending
AIMS2D Arthritis Impact Measurement Scale2 Dutch PhysA Physical Activities
WaBe Walking and Bending
AIMSS AIMS short version PhysA Physical Activities
ASES Arthritis Self Efficacy Scale FSE Functional Self Efficacy
BIM Barthel Index Modified
DPI Functional Index (Dutch)
E-QoL Euro Quality of Life Scale
FAS Functional Assessment Survey Aids Aid-tools
Trans Transport
FIQ Functional Index Questionnaire PhysF Physical Function
FSAI Functional Status Assessment Instrument
FSI Functional Status Index GlobH Global Health
Mob Mobility
GARS Groninger Activity Restriction Scale ADL Activities of Daily Living
HAQ Health Assessment Questionnaire Disab Disabilities
GlobH Global Health
Mob Mobility
ODI Overall Disability Index
OthAc Other Activities
Walk Walking
IRGL Invloed van Rheuma op Gezondheid en Leefwijze Mob Mobility
IWB Index of Well Being GlobH Global Health
Mob Mobility
KFT Keitel Functional Test
LDQ Leeds Disability Questionnaire
MDR MDR-Index
M FAQ Musculoskeletal Function Assessment Questionnaire
MHAQ Modified Health Assessment Questionnaire ODIOthAc
Overall Disability Index
Other Activities
Walk Walking
MPPDQ MACTAR Patient Preference Disability Questionnaire
MUMQ Maastricht Utility Measurement Questionnaire
NHP Nothingham Health Profile PhysM Physical Mobility
OSRA Overall Status in Rheumatoid Arthritis
RAQoL Rheumatoid Arthritis Quality of Life Scale
SF-36 Short Form 36 PhysA
Physical Activities
SIP Sickness Impact Profile GlobHMob
Global Health
Mobility
PItysH Physical Health
SRQ Self-Report Questionnaire
SW Stair Walk
WOMAC WOMAC-Osteoarthritis Index Disab
Disabilities
WT Walking time-50 foot
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